Elizabeth J. Phillips, MD
Professor of Medicine
Division
Infectious Diseases
Director, Center for Drug Safety and Immunology
Professor of Medicine, Pharmacology & Pathology, Microbiology & Immunology
John A. Oates Chair in Clinical Research
Professional Bio
Elizabeth J. Phillips, MD, is a Professor of Medicine in the Division of Infectious Diseases within the Department of Medicine at Vanderbilt University Medical Center.
Dr. Phillips holds the John A. Oates Chair in Clinical Research. Her lab has a research and clinical program in drug hypersensitivity that specifically focuses on the tissue specificity, genetic basis and immunopathogenesis of severe T-cell mediated adverse drug reactions such as Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis and drug reaction with eosiniophiia and systemic symptoms. Her lab studies the development of genetic, molecular and cellular signals to predict and prevent these severe life-threatening adverse drug reactions using novel single cell technologies and mass cytometry.
Dr. Phillips has had an international impact as she has forged collaborations with groups in Australia, Africa and Southeast Asia to guide in the implementation of scientific programs to study the expansive and genetically diverse drug hypersensitivity syndromes. This research program is paired with an outpatient clinical drug allergy service which occurs weekly at VASAP.
Dr. Phillips holds the John A. Oates Chair in Clinical Research. Her lab has a research and clinical program in drug hypersensitivity that specifically focuses on the tissue specificity, genetic basis and immunopathogenesis of severe T-cell mediated adverse drug reactions such as Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis and drug reaction with eosiniophiia and systemic symptoms. Her lab studies the development of genetic, molecular and cellular signals to predict and prevent these severe life-threatening adverse drug reactions using novel single cell technologies and mass cytometry.
Dr. Phillips has had an international impact as she has forged collaborations with groups in Australia, Africa and Southeast Asia to guide in the implementation of scientific programs to study the expansive and genetically diverse drug hypersensitivity syndromes. This research program is paired with an outpatient clinical drug allergy service which occurs weekly at VASAP.
Education
MD - University of Alberta - 1989
Internship - General - University of Ottawa - 1990
Residency - Internal Medicine - University of Toronto - 1993
Fellowship - Infectious Disease - University of Toronto - 1995
Fellowship - Medical Microbiology - University of Toronto - 1996
Fellowship - Clinical Pharmacology - University of Toronto - 1998